Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a research note released on Wednesday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Trading Up 3.4 %

NYSE RVP opened at $0.75 on Wednesday. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The company has a fifty day simple moving average of $0.78 and a two-hundred day simple moving average of $0.75. Retractable Technologies has a 12-month low of $0.56 and a 12-month high of $1.23. The stock has a market cap of $22.46 million, a P/E ratio of -1.39 and a beta of 2.08.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Retractable Technologies stock. Renaissance Technologies LLC grew its stake in Retractable Technologies, Inc. (NYSE:RVP) by 9.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 361,253 shares of the company’s stock after purchasing an additional 31,140 shares during the quarter. Renaissance Technologies LLC owned approximately 1.21% of Retractable Technologies worth $249,000 as of its most recent SEC filing. Institutional investors and hedge funds own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.